These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 39861)

  • 21. Beta-adrenergic blockade in some cardiovascular diseases.
    Tarazi RC
    Cardiovasc Clin; 1975; 7(1):173-85. PubMed ID: 238741
    [No Abstract]   [Full Text] [Related]  

  • 22. [Hemodynamic effect of beta receptor blockaders in arterial hypertension].
    Anlauf M; Bock KD
    Verh Dtsch Ges Inn Med; 1974; 80():189-99. PubMed ID: 4156112
    [No Abstract]   [Full Text] [Related]  

  • 23. Plasma renin activity after the use of a new beta-adrenergic blocking agent (I.C.I. 66,032).
    Aberg H
    Int J Clin Pharmacol; 1974 Mar; 9(2):98-100. PubMed ID: 4151244
    [No Abstract]   [Full Text] [Related]  

  • 24. [The significance of beta-adrenergic receptor blocking agents in the treatment of hypertension].
    Lydtin H
    Med Welt; 1975 Aug; 6(35):1487-92. PubMed ID: 240998
    [No Abstract]   [Full Text] [Related]  

  • 25. Hemodynamic effects of nifedipine in hypertension in the presence of elevated angiotensin-II and beta-adrenergic blockade.
    Blau A; Battler A; Eldar M; Rath S; Neufeld HN; Kapuler S; Iaina A; Cohen D; Eliahou HE
    J Clin Hypertens; 1986 Mar; 2(1):13-20. PubMed ID: 2873210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [State of the sympathetic-adrenal system and renin activity in the blood in children with primary arterial hypertension in the process of beta-blockader treatment].
    Nebol'sina LI; Pinelis VG; Kurbatov VS; Nadezhdina EA; Markov KhM
    Kardiologiia; 1978 Nov; 18(11):38-42. PubMed ID: 31507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of calcium antagonist, angiotensin-converting enzyme inhibitors and beta-blocker on hemodynamic and sympathetic nerve responses to exercise in essential hypertension].
    Fujiwara S; Arita M; Ueno Y; Shiotani M; Nakatsu C; Nakamura Y; Hano T; Nishio I; Masuyama Y
    J Cardiol; 1991; 21(1):115-24. PubMed ID: 1687786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Adrenergic beta receptor blockaders in arterial hypertension].
    Rodríguez-Navarro CQ; Maceira Cruz B; Fernández Andrade C; Ortega Amaya J; Garcia de Pesquera F; López Solbes R; Castilla Jiménez J; Mateos Aguilar J
    Rev Clin Esp; 1975 Nov; 139(4):345-51. PubMed ID: 1828
    [No Abstract]   [Full Text] [Related]  

  • 29. Hemodynamic and adrenergic responses of bevantolol and propranolol in hypertensives.
    Snedden W; Fernandez PG; Vasdev S; Bolli P
    Can J Cardiol; 1989; 5(1):37-41. PubMed ID: 2563955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Essential hypertension: Renin and aldosterone, key to pathogeny and therapy?].
    Bühler FR
    Schweiz Med Wochenschr; 1974 Jul; 104(29):1013-22. PubMed ID: 4153738
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of enalapril maleate on blood pressure, renin-angiotensin-aldosterone system, and peripheral sympathetic activity in essential hypertension.
    Cerasola G; Cottone S; D'Ignoto G; Grasso L; Carone MB; Carapelle E; Contorno A
    Clin Ther; 1987; 9(4):390-9. PubMed ID: 3038326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Behavior of cardiac output, plasma volume, plasma renin activity and aldosterone secretion in patients with essential hypertension treated with beta-blocking agents and diuretics].
    Salerno L; Licata G; Sparacino V; Custro N; Indovina I
    Clin Ter; 1979 Aug; 90(3):223-32. PubMed ID: 45260
    [No Abstract]   [Full Text] [Related]  

  • 33. [Hemodynamic and hormonologic basis of the treatment of arterial hypertension].
    Guédon J; Lucsko M; Chaignon M
    Arch Mal Coeur Vaiss; 1974 Oct; 67(10):1145-55. PubMed ID: 4156640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does blockade of the renin angiotensin system affect sympathetic and blood pressure responses to amlodipine in young hypertensive patients?
    Ruzicka M; Coletta E; Leenen FH
    Am J Hypertens; 2007 Nov; 20(11):1202-8. PubMed ID: 17954368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hemodynamics of hypertension. Changes caused by beta-blocking agents].
    Mattioli G; Ricci S; Bertoncelli P
    Minerva Cardioangiol; 1979; 27(7-8):463-72. PubMed ID: 44898
    [No Abstract]   [Full Text] [Related]  

  • 36. Evaluation of practolol in hypertension. Effects on sympathetic nervous system and renin responsiveness.
    Esler MD; Nestel PJ
    Br Heart J; 1973 May; 35(5):469-74. PubMed ID: 4146053
    [No Abstract]   [Full Text] [Related]  

  • 37. [Beta adrenergic receptor blockade in the treatment of arterial hypertension].
    Sznajderman M
    Kardiol Pol; 1976; 19(3):173-9. PubMed ID: 9530
    [No Abstract]   [Full Text] [Related]  

  • 38. Beta-adrenergic blockade in hypertension.
    Hansson L; Werkö L
    Am Heart J; 1977 Mar; 93(3):394-402. PubMed ID: 14497
    [No Abstract]   [Full Text] [Related]  

  • 39. [Blocking of the renin-angiotensin-aldosterone system in the study and treatment of arterial hypertension].
    Villarreal H
    Arch Inst Cardiol Mex; 1983; 53(1):1-3. PubMed ID: 6135394
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacological mechanism of angiotensin II receptor antagonists: implications for the treatment of elevated systolic blood pressure.
    Brooks DP; Ruffolo RR
    J Hypertens Suppl; 1999 Jun; 17(2):S27-32. PubMed ID: 10465064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.